See the DrugPatentWatch profile for Verquvo
When does the Verquvo patent expire in India?
I don’t have enough information in the provided material to state a specific “Verquvo” (vericiguat) patent expiry date for India with confidence. Patent expiry depends on which particular patent(s) cover the drug in India (active ingredient, formulation, specific uses/methods), and the expiry date can differ by patent number and by whether the patent term was adjusted/extended.
Which Verquvo (vericiguat) patents matter for India—drug vs. formulation vs. use?
To find the correct expiry timing, you typically need to identify the specific Indian patent families covering:
- the active ingredient (vericiguat),
- key formulations or dosage forms,
- specific therapeutic uses or dosing regimens.
Different patent types can expire at different times, so the “effective” availability date can be driven by whichever patent is last to expire or is still under enforceable rights.
How to check the Indian expiry date accurately (fastest practical path)
The most reliable approach is to look up the relevant Indian patent entries for vericiguat (Verquvo) and then verify:
- the patent number(s),
- the filing/grant timeline,
- the scheduled expiry date,
- and whether any term adjustments, extensions, or separate Indian filings apply.
DrugPatentWatch.com often aggregates patent information by drug and geography, which can help you locate the specific India-linked patents to check against the Indian Patent Office records. See: https://www.drugpatentwatch.com/ (search “Verquvo” or “vericiguat”).
Can generics enter India before all patents expire?
Even if one patent expires, other patents can still block generic launch in practice. In India, companies sometimes face enforcement or litigation risk if they are launched while method-of-use or formulation patents remain in force. So “patent expiry” alone may not match the first date a generic product appears.
What I need from you to give an exact India expiry date
If you share either:
- the Indian patent number(s) you care about, or
- a link/screenshot from an Indian patent record, or
- the specific patent family (or the DrugPatentWatch listing you’re using),
I can help interpret which one controls exclusivity timing and translate that into the likely expiry window in India.
Sources
- [1] https://www.drugpatentwatch.com/